Evidence map›Paper›PMID 37755892›Full record

ArticleTropical medicine and infectious disease2023

How Hypertension Rates and HIV Treatment Outcomes Compare between Older Females and Males Enrolled in an HIV Treatment Program in Southern Nigeria: A Retrospective Analysis.

Uduak Akpan, Moses Bateganya, Otoyo Toyo, Esther Nwanja, Chiagozie Nwangeneh, Onwah Ogheneuzuazo, Augustine Idemudia, Ezekiel James, Dolapo Ogundehin, Adeoye Adegboye and 2 more

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Uduak AkpanExcellence Community Education Welfare Scheme (ECEWS), Uyo 520101, Nigeria.
Moses BateganyaFamily Health International (FHI 360), Durham, NC 27701, USA.ORCID 0000-0001-9442-7854
Otoyo ToyoExcellence Community Education Welfare Scheme (ECEWS), Uyo 520101, Nigeria.
Esther NwanjaExcellence Community Education Welfare Scheme (ECEWS), Uyo 520101, Nigeria.
Chiagozie NwangenehFamily Health International (FHI 360), Durham, NC 27701, USA.
Onwah OgheneuzuazoExcellence Community Education Welfare Scheme (ECEWS), Uyo 520101, Nigeria.ORCID 0009-0007-9491-6253
Augustine IdemudiaFamily Health International (FHI 360), Durham, NC 27701, USA.ORCID 0000-0002-2193-6401
Ezekiel JamesUS Agency for International Development, Abuja 900211, Nigeria.
Dolapo OgundehinUS Agency for International Development, Abuja 900211, Nigeria.
Adeoye AdegboyeExcellence Community Education Welfare Scheme (ECEWS), Uyo 520101, Nigeria.
Okezie OnyedinachiExcellence Community Education Welfare Scheme (ECEWS), Uyo 520101, Nigeria.ORCID 0000-0001-6085-4831
Andy EyoExcellence Community Education Welfare Scheme (ECEWS), Uyo 520101, Nigeria.
Excellence Community Education Welfare Scheme · NGFamily Health International 360 · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies show that treatment outcomes may vary among persons living with HIV. To fast-track the attainment of epidemic control across gender and age groups, the Accelerating Control of the HIV Epidemic (ACE-5) Project implemented in Akwa Ibom and Cross Rivers States, Nigeria, examined the hypertension rates and treatment outcomes of older adults living with HIV. The demographic and treatment characteristics of males and females ≥ 50 years living with HIV, who initiated antiretroviral therapy (ART) as of September 2021, were abstracted from medical records across 154 health facilities and community sites in Akwa Ibom and Cross River states, Nigeria. We compared these characteristics by sex using the chi-square test. The log-rank test was used to compare differences in their retention (i.e., being on treatment) and viral suppression (VS) rates [<1000 copies/Ml] in September 2022. Of the 16,420 older adults living with HIV (10.8% of the treatment cohort) at the time of the study, 53.8%, and 99.5% were on a first-line ART regimen. Among the 3585 with baseline CD4 documented (21.8% of the cohort), the median [IQR] CD4 count was 496 [286-699] cells/mm

Indexed as

geriatricsHIV/AIDSretentionsex distributionviral load suppression

Identifiers

PMID37755892
PMCPMC10536592
OpenAlexW4386324310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.